The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Monday, November 29, 2021
Merck and Eisai announced that the European Commission has approved the combination of KEYTRUDA, Merck’s anti-PD-1 therapy, plus LENVIMA, the orally ...
read more
Monday, November 29, 2021
Valneva a specialty vaccine company, and IDT Biologika announced their collaboration for the production of Valneva’s inactivated COVID-19 vaccine ...
read more
Wednesday, November 24, 2021
Seqirus, a business of CSL Limited, announced that the FDA has granted supplemental approval of a multi-dose vial (MDV) presentation of AUDENZ™ (...
read more
Wednesday, November 24, 2021
Takeda Pharmaceutical Company Limited announced that the FDA has approved LIVTENCITY™ (maribavir) for the treatment of adults and pediatric patients (...
read more
Wednesday, November 24, 2021
The Janssen Pharmaceutical Companies of Johnson & Johnson announced that Health Canada has approved its single-shot COVID-19 vaccine to prevent COVID-...
read more
Tuesday, November 23, 2021
Bristol Myers Squibb today announced that the European Commission has granted a Marketing Authorization for Zeposia (ozanimod) for the treatment of ...
read more
Monday, November 22, 2021
REGENXBIO Inc. announced the FDA granted Orphan Drug Designation for RGX-202, a potential one-time gene therapy for the treatment of Duchenne muscular...
read more
Friday, November 19, 2021
New data from the AZD7442 COVID-19 PROVENT prevention and TACKLE outpatient treatment Phase III trials both showed robust efficacy from a one-time ...
read more
Friday, November 19, 2021
BioNTech SE announced that the FDA granted Fast Track Designation for BNT111, an investigational cancer immunotherapy for the potential treatment of ...
read more
Friday, November 19, 2021
Amneal Pharmaceuticals, Inc. has received Abbreviated New Drug Application (ANDA) approval from the U.S. FDA for difluprednate ophthalmic emulsion 0....
read more
Friday, November 19, 2021
Bristol Myers Squibb announced that the FDA has extended the review of the New Drug Application (NDA) for mavacamten for the treatment of patients ...
read more
Friday, November 19, 2021
Merck announced an update regarding the Phase 2 IMAGINE-DR clinical trial (MK-8507-13), which is evaluating the investigational combination of MK-8507...
read more
Thursday, November 18, 2021
Merck announced that the FDA has approved KEYTRUDA, Merck’s anti-PD-1 therapy, for the adjuvant treatment of patients with renal cell carcinoma (RCC) ...
read more
Tuesday, November 16, 2021
Health Canada has authorized the use of the Moderna Spikevax COVID-19 vaccine as a booster shot. A COVID-19 booster shot is an extra dose of the ...
read more
Tuesday, November 16, 2021
The FDA approved Besremi (ropeginterferon alfa-2b-njft) injection to treat adults with polycythemia vera, a blood disease that causes the ...
read more